hansoh glp-1 Merck moves into obesity with deal for Hansoh's pill Regeneron & Hansoh's GLP-1 Deal

International journal of molecular sciences, 19(7), 1987.

What the class is approved to treat Indications vary by product: type 2 diabetes for most, chronic weight management for Wegovy, Saxenda, and Zepbound, cardiovascular risk reduction in type 2 diabetes for Ozempic, Trulicity, Victoza, and Rybelsus, and obstructive sleep apnea in adults with obesity for Zepbound (December 2024)

Carnitine is responsible for the movement of longchain fatty acids (FAs) into the mitochondria for oxidation through the action of carnitine palmitoyltransferase1 (CPT1) (Longo et al., 2016)

The diagnosis of SGLT2 inhibitor-associated DKA was established if cases met the following criteria: (1) prior diagnosis of type 1 diabetes mellitus or T2DM